Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American Well Corp (AMWL) vs Altria Group Inc (MO) Price & Performance

American Well CorpTrade
Altria Group IncTrade

Price performance (Past 24H)

Key statistics

American Well Corp vs Altria Group Inc — how do they compare? American Well Corp trades at $12.46 (market cap $220.94M), while Altria Group Inc trades at $64.57 (market cap $108.58B). The key difference: Altria Group Inc is far larger — about 491.4× American Well Corp's market cap, and Altria Group Inc pays a 6.52% dividend while American Well Corp pays none. Which is the better fit depends on your goals.

AMWLMO
Market Cap
$220.94M$108.58B
Sector
HealthConsumer Staples
52-Week High
$13.58$74.92
52-Week Low
$3.78$54.72
Enterprise Value
$27.98M$130.79B
Dividend Yield
6.52%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

American Well Corp

AMWL trades at $12.54, down 7.66% today, with a bullish technical signal from moving averages but overbought RSI readings. The company shows improving financial trends, with revenue declining to $249.33M in 2025 but net losses narrowing significantly to -$95.70M. Recent Q2 2026 earnings beat expectations, and news highlights strategic developments including a key executive appointment at Amazon's healthcare unit.

The outlook suggests cautious optimism as AMWL progresses toward cash-flow breakeven, supported by analyst coverage leaning Hold. Key risks include persistent revenue declines and high cash burn, though improving margins and reduced losses indicate potential for recovery if execution continues.

Altria Group Inc

Altria Group (MO) trades at $64.47, down 1.63% today, with a bearish technical signal despite oversold RSI readings near 18-27. The company maintains strong profitability with 39% net income margins and a 6.3% dividend yield, though recent earnings show mixed results with two misses in the last four quarters. Cash flow improved significantly in 2025 with $1.33B net inflow, while debt remains elevated at $23.4B long-term.

Investment outlook balances high yield and dividend consistency against cigarette volume declines and regulatory risks. Analyst consensus remains bullish with a $67 price target, but ongoing litigation investigations and smoke-free transition execution pose significant challenges. The stock offers value at 13.7x P/E but requires careful monitoring of diversification efforts.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About American Well Corp

American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.

Read more on AMWL

About Altria Group Inc

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).

Read more on MO